Top Markets
Coin of the day
Quantum Genomics S.A. Quantum Genomics S.A.

Quantum Genomics S.A.

ALQGC
Kedudukan dalam Saham #37063
Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France,... Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France, in 2005, focuses on creating treatments for cardiovascular ailments. Its therapeutic approach utilizes the brain aminopeptidase A inhibition (BAPAI) platform, primarily addressing high blood pressure (hypertension) and heart failure. The company's key asset, firibastat, is currently undergoing a crucial Phase III study as a standalone therapy for hypertension and is also in clinical trials for heart failure. Additionally, Quantum Genomics is progressing QGC011 for hypertension in combination therapy, and further developing QGC006 and QGC606 to target both hypertension and heart failure.
Harga Saham
$0.07600875
Disegerakkan terakhir: 2024-11-20
Modal Pasaran
$2.06M
Perubahan (1 hari)
-0.51%
Perubahan (1 tahun)
0.00%
Negara
FR
Perdagangan Quantum Genomics S.A. (ALQGC)

Kategori

EPS untuk Quantum Genomics S.A. (ALQGC)
EPS setakat December 2024 TTM: $-0.26
Menurut laporan kewangan terkini dan harga saham Quantum Genomics S.A., EPS semasa syarikat (TTM) adalah $-0.26. Pada akhir tahun 2023, syarikat mempunyai EPS sebanyak $-0.10 penurunan berbanding EPS tahun 2022 iaitu $-0.77.
Sejarah EPS untuk Quantum Genomics S.A. dari 2009 hingga 2026
EPS pada akhir setiap tahun
Tahun EPS Ubah
2026 (TTM) $-0.26 85.79%
2024 $-0.14 34.49%
2023 $-0.10 -86.97%
2022 $-0.77 6.11%
2021 $-0.73 -24.35%
2020 $-0.96 71.50%
2019 $-0.56 -35.77%
2018 $-0.87 -15.36%
2017 $-1.03 55.66%
2016 $-0.66 13.06%
2015 $-0.59 5.34%
2014 $-0.56 9.39%
2013 $-0.51 1.50%
2012 $-0.50 -89.65%
2011 $-4.84 -37.57%
2010 $-7.75 -10.46%
2009 $-8.66 0.00%
EPS untuk syarikat atau pesaing yang serupa
Syarikat EPS Perbezaan EPS Negara
$17.32 -6,758.98%
US
$27.74 -10,765.13%
NL
- -
CH
- -
KR
$13.70 -5,367.24%
BE